AmBisome®

A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis

Olorofim Aspergillus Infection Study

Single High-dose of Liposomal Amphotericin B in Combination With B/F/TAF for HIV/AIDS-associated Talaromycosis

Bioequivalence of Amphotericin B Liposome for Injection

Pharmacokinetics and Safety of AmBisome and DKF-5122

A Pilot Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome® in Healthy Subjects

Short Course Regimens for Treatment of PKDL (Sudan)

Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh

PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia

COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis

Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis

An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects

SCH708980 With and Without AmBisome for Visceral Leishmaniasis

Antimicrobial PK in Infants With Suspected or Confirmed Infection

Safety and Efficacy Study of Inhaled AmBisome for Prevention of Aspergillus Colonization in Lung Transplant Recipients

Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants

PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation

CRITIC - Treatment of Candidemia and Invasive Candidiasis

Ambisome in Liver Transplant Patients

Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment